When a biotech company announces positive Phase 3 trial results or receives FDA approval, the market reaction is often immediate and substantial. This is not just speculation. These milestones ...

The world is now looking to Australia’s lead on protecting artists copyright from artificial intelligence, says the chief ...

Here is the AI research roadmap for 2026: how agents that learn, self-correct, and simulate the real world will redefine ...

Hut 8 Corp. has signed a 15-year, $7.0 billion lease agreement tied to its River Bend data center campus in West Feliciana Parish, a project ...

This important study reports three experiments examining how the subjective experience of task regularities influences perceptual decision-making. Although the evidence linking subjective ratings to ...

Credo’s AEC cable boom is beating revenue and lifting guidance; hyperscaler ramps add upside. Read here for an investment ...

In the latest in our series identifying market opportunities for the channel, the spotlight falls on getting customers in the right place to adopt artificial intelligence.

An expert Q&A on the legal, ethical, and practical considerations and emerging issues regarding judicial use of AI, including ...

The most interesting price discussions usually start before the crowd notices. When analysts begin modeling large upside ...

Crypto's retroactive funding rewards proven impact, not promises. But Optimism's $100M experiment reveals why applying this ...

Examine how the American Cancer Society’s national ACTS expansion is designed to simplify trial discovery, reduce logistical ...

From securing MCPs and supply chain defenses to formal AI and quantum governance, experts share their wish lists for cyber ...